CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Subcutaneous insulin therapy was associated with shorter ...

The Institute for Endocrinology and Diabetes, Schneider Children's Medical Center, Petah Tikva, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Faculty of Medicine, University of ...

A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with ...

Whether improved glucose control with hybrid closed-loop therapy can preserve C-peptide secretion as compared with standard insulin therapy in persons with new-onset type 1 diabetes is unclear. In a ...

With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the ...

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...

Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people. New automated insulin delivery pumps have significantly improved diabetes care, ...

As autoimmune diseases continue to place a growing burden on healthcare systems worldwide, the field has started to move beyond immunosuppressive therapies that slow decline without meaningfully ...

Leo, a 22-year-old man who received a diagnosis of type 1 diabetes at 17 years of age, has struggled to meet glucose targets. As a young adult, he has many competing priorities, and diabetes is not ...